Alzheimer’s Disease Contract Research Organization Services

Looking for a client-focused contract research organization (CRO) to support an upcoming Alzheimer’s disease clinical trial?

PharPoint’s experts can work as an extension of your team to help you strategically plan, execute, and analyze Phase 1 – Phase 4 clinical trials.

Fill out the form below for more information about our Alzheimer’s Disease CRO experience, including:

Overcoming common challenges in Alzheimer’s Disease trials
PharPoint’s relevant study experience
Identifying and partnering with the right sites
Leveraging innovative trial technology
PharPoint’s industry-best biometrics timelines, from Last Patient, Last Visit and Source Document Verification (LPLV/SDV) to clinical study report (CSR) delivery
Service offering

Ready to get into specifics on how PharPoint can help you meet your Alzheimer’s Disease clinical trial goals?

We’d love to chat details! Schedule an introductory meeting with our business development team here.

← Back to Resource Library

DOWNLOAD

Supporting Clinical Trials within Alzheimer’s Disease

Learn how PharPoint supports Alzheimer’s disease-focused clinical trials.

PharPoint’s Alzheimer’s Experience

Our team offers comprehensive support, including study design, patient recruitment strategies, regulatory navigation, and data management tailored to neurodegenerative disease research. PharPoint’s deep understanding of Alzheimer’s disease trials, coupled with our focus on quality and efficiency, enables us to support the development of treatments aimed at slowing and preventing Alzheimer’s disease.

RELATED RESOURCES

Experience Overview

Alzheimer's Disease & Decentralized Clinical Trials

Success Story: Neonatal Cardiovascular Rescue